Company intelligence / Profile preview

弘亮

Ownership: Private
Development stage: Other

Overview

Hongliang Biotech is a synthetic biology company based in Suzhou, China, specializing in high-throughput protein engineering and enzyme evolution. The company utilizes its proprietary platform to design and optimize proteins for applications in pharmaceuticals, industrial biocatalysis, and fine chemicals. By integrating computational design with experimental screening, Hongliang Biotech aims to accelerate the development of novel biocatalysts and therapeutic protein candidates. The firm focuses on the directed evolution of enzymes to improve their stability, activity, and specificity for commercial use.

Therapeutic areas: Other
Modalities: Recombinant proteinBiologicEnzyme
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on 弘亮.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 弘亮.

Explore the full profile